UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000025777 |
|---|---|
| Receipt number | R000029641 |
| Scientific Title | A study to evaluate the exposure to selected smoke constituents in healthy smokers using B-003 for 5 days confined in a hospital |
| Date of disclosure of the study information | 2017/12/15 |
| Last modified on | 2018/11/13 17:29:03 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
A study to evaluate the exposure to selected smoke constituents in healthy smokers using B-003 for 5 days confined in a hospital
Acronym
A study to evaluate the exposure to selected smoke constituents when using B-003
Scientific Title
A study to evaluate the exposure to selected smoke constituents in healthy smokers using B-003 for 5 days confined in a hospital
Scientific Title:Acronym
A study to evaluate the exposure to selected smoke constituents when using B-003
Region
| Japan |
Condition
Condition
Smokers
Classification by specialty
| Not applicable |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To investigate the exposure to selected smoke constituents in smokers switching to B-003 confined in a hospital
Basic objectives2
Others
Basic objectives -Others
To investigate the exposure to selected smoke constituents in smokers using their own brands of comercial cigarettes or abstaining from smoking confined in a hospital
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
The difference of biomarkers of exposure to selected smoke constituents between the investigational tobacco products
Key secondary outcomes
Base
Study type
Interventional
Study design
Basic design
Parallel
Randomization
Randomized
Randomization unit
Individual
Blinding
Open -no one is blinded
Control
No treatment
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
3
Purpose of intervention
Prevention
Type of intervention
| Food |
Interventions/Control_1
(Smokers) Use of subject's own brand for 2 days (confined in a hospital)
Use of B-003 for 5 days (confined in a hospital)
Interventions/Control_2
(Smokers) Use of subject's own brand for 2 days (confined in a hospital)
Continued use of of subject's own brand for 5 days (confined in a hospital)
Interventions/Control_3
(Smokers) Use of subject's own brand for 2 days (confined in a hospital)
Abstinence from smoking for 5 Days (confined in a hospital)
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 21 | years-old | <= |
Age-upper limit
| 65 | years-old | > |
Gender
Male and Female
Key inclusion criteria
Subjects who sign the study-specific consent form
Subjests who are confirmed to be in good health from all of the inspection results
Smokers
etc.
Key exclusion criteria
Subjects who have used tobacco products other than commercial cigarettes (i.e.hand-rolled cigarettes, cigarillos, cigars, pipes, snuff tobacco, chewing tobacco, etc.) within one week before screening
Pregnant or lactating women or women who may be pregnant
etc.
Target sample size
60
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Yasuyuki Futamura |
Organization
JAPAN TOBACCO INC.
Division name
Scientific product assessment center, Tobacco Business Headquarters
Zip code
Address
6-2, Umegaoka, Aoba-ku, Yokohama, Kanagawa
TEL
045-345-5222
yasuyuki.futamura@jt.com
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Kyoko Nakaya |
Organization
JAPAN TOBACCO INC.
Division name
Scientific product assessment center, Tobacco Business Headquarters
Zip code
Address
6-2, Umegaoka, Aoba-ku, Yokohama, Kanagawa
TEL
045-345-5150
Homepage URL
kyoko.nakaya@jt.com
Sponsor or person
Institute
JAPAN TOBACCO INC.
Institute
Department
Personal name
Funding Source
Organization
JAPAN TOBACCO INC.
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2017 | Year | 12 | Month | 15 | Day |
Related information
URL releasing protocol
Publication of results
Published
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2016 | Year | 11 | Month | 30 | Day |
Date of IRB
Anticipated trial start date
| 2017 | Year | 01 | Month | 21 | Day |
Last follow-up date
| 2017 | Year | 02 | Month | 22 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2017 | Year | 01 | Month | 20 | Day |
Last modified on
| 2018 | Year | 11 | Month | 13 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000029641
